Tavexia Lifecare Limited (BOM:539519)
India · Delayed Price · Currency is INR 1.200
+0.010 (0.84%)
At close: Oct 7, 2026
Tavexia Lifecare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 316.78 | 322.49 | 52.63 | 35.53 | 22.13 | 15.4 |
Other Revenue | - | - | - | - | - | 0.1 |
| 316.78 | 322.49 | 52.63 | 35.53 | 22.13 | 15.5 | |
Revenue Growth | 447.81% | 512.74% | 48.12% | 60.58% | 42.76% | 20.04% |
Cost of Revenue | 349.3 | 352.24 | 8.68 | 10.37 | 3.21 | 8 |
Gross Profit | -32.52 | -29.75 | 43.95 | 25.16 | 18.92 | 7.5 |
Selling, General & Admin | 5.61 | 5.98 | 3.57 | 3.2 | 4.23 | 4.2 |
Other Operating Expenses | 23.29 | 15.55 | 7.83 | 2.7 | 4.55 | 2.2 |
Operating Expenses | 35.04 | 27.04 | 15.65 | 9.74 | 11.01 | 7 |
Operating Income | -67.56 | -56.79 | 28.31 | 15.42 | 7.91 | 0.5 |
Interest Expense | -0.81 | -0.38 | -0.47 | -0.14 | -0.32 | -0.19 |
Other Non Operating Income (Expenses) | 60.01 | 55.78 | 3.64 | 0.04 | 0.03 | -0.01 |
EBT Excluding Unusual Items | -8.36 | -1.4 | 31.48 | 15.32 | 7.62 | 0.3 |
Gain (Loss) on Sale of Investments | - | 3.07 | - | - | - | - |
Gain (Loss) on Sale of Assets | - | - | 0.39 | - | - | - |
Pretax Income | -8.36 | 1.66 | 31.87 | 15.32 | 7.62 | 0.3 |
Income Tax Expense | -2.36 | -0.45 | 6.97 | 3.42 | 2.08 | 0.1 |
Net Income | -6.35 | 2.12 | 24.9 | 11.9 | 5.54 | 0.2 |
Net Income to Common | -6.35 | 2.12 | 24.9 | 11.9 | 5.54 | 0.2 |
Net Income Growth | - | -91.50% | 109.13% | 115.07% | 2667.50% | -95.47% |
Shares Outstanding (Basic) | 228 | 384 | 192 | 192 | 128 | 51 |
Shares Outstanding (Diluted) | 228 | 384 | 192 | 192 | 128 | 51 |
Shares Change | 15.55% | 99.74% | -0.18% | 49.84% | 150.78% | - |
EPS (Basic) | -0.03 | 0.01 | 0.13 | 0.06 | 0.04 | 0.00 |
EPS (Diluted) | -0.03 | 0.01 | 0.13 | 0.06 | 0.04 | 0.00 |
EPS Growth | - | -95.74% | 111.46% | 44.23% | 988.07% | -95.47% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -175.31 | -3.73 | -27.71 | -30.49 | -11.4 |
Free Cash Flow Per Share | - | -0.46 | -0.02 | -0.14 | -0.24 | -0.22 |
Gross Margin | -10.27% | -9.22% | 83.51% | 70.81% | 85.51% | 48.39% |
Operating Margin | -21.33% | -17.61% | 53.79% | 43.40% | 35.76% | 3.23% |
Profit Margin | -2.00% | 0.66% | 47.30% | 33.50% | 25.01% | 1.29% |
Free Cash Flow Margin | - | -54.36% | -7.08% | -77.98% | -137.79% | -73.55% |
EBITDA | -61.72 | -51.27 | 32.55 | 19.27 | 10.14 | 1.1 |
EBITDA Margin | -19.48% | -15.90% | 61.84% | 54.22% | 45.82% | 7.10% |
D&A For EBITDA | 5.84 | 5.52 | 4.24 | 3.85 | 2.23 | 0.6 |
EBIT | -67.56 | -56.79 | 28.31 | 15.42 | 7.91 | 0.5 |
EBIT Margin | -21.33% | -17.61% | 53.79% | 43.40% | 35.76% | 3.23% |
Effective Tax Rate | - | - | 21.88% | 22.31% | 27.35% | 33.33% |
Revenue as Reported | 376.79 | 381.34 | 56.67 | 35.57 | 22.17 | 15.5 |
Advertising Expenses | - | 0.54 | 0.22 | 0.04 | 0.09 | - |